Actelion Pharmaceuticals Ltd v. Bristol-Myers Squibb Co

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Claire C. Cecchi · 12,702 cases in index

Docket number

2:21-cv-18695

Cause

15:1126 Patent Infringement
15 U.S.C. § 1126

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal Question

Jury demand

Both

Date filed

10/15/2021

Date terminated

10/30/2024

3,648 Patent cases in this court are indexed here.

Parties

• plaintiff · Actelion Pharmaceuticals Ltd · 23 cases
• defendant · Bristol-Myers Squibb Pharmaceuticals & Biotechnology · 9426 cases

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is Actelion Pharmaceuticals Ltd v. Bristol-Myers Squibb Co?

Actelion Pharmaceuticals Ltd v. Bristol-Myers Squibb Co is a federal patent lawsuit filed on 10/15/2021 in the District Court, D. New Jersey. The case was terminated on 10/30/2024. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 2:21-cv-18695.

When was the case filed?

Actelion Pharmaceuticals Ltd v. Bristol-Myers Squibb Co was filed on 10/15/2021. It was terminated on 10/30/2024.

What law is the case brought under?

The docket lists the cause as 15 U.S.C. § 1126.